Oral Cancer Treatment Market Research Report – Forecast till 2027

Oral Cancer Treatment Market Research Report, By Type (Squamous Cell Carcinoma, Minor Salivary Gland Carcinomas), Treatment (Surgery, Radiotherapy, Chemotherapy), End Users (Research Organization, Academic Institutes) - Forecast till 2027

ID: MRFR/Pharma/1288-HCR | February 2021 | Region: Global | 90 pages

Oral Cancer Treatment Market Overview:


The oral cancer treatment market is one of the rapidly improving market structures which is projected to achieve better future results due to the rising number of cases of oral cancer surgeries which leads to continuous investments being made towards the establishment and growth of the oral cancer treatment market size and share.


Oral cancer is another form of the deadly disease which has been diversified in terms of various types of oral cancers which include squamous cell carcinoma, verrucous carcinoma, minor salivary glands carcinoma, lymphomas, and other types which have been proven to be deadly and dangerous in terms of population affected by them. Though oral cancers are non-communicable forms of disease they have been affecting a large portion of the population all around the globe.


According to the oral cancer foundation, 53000 new cases of oral cancer arise every year and around 10000 people lose their lives due to deadly cancer. The main symptoms of oral cancers are normal but clinical such as sore throat, pain in the gums, swelling around the lips, and the entire face. These symptoms are a clear indication of oral cancer and if not cured immediately and properly can lead to spreading to the entire body. However, improved health care facilities and advancements in technology have led to the improvement in the oral cancer treatment market.


The oral cancer treatment market is expected to grow at a CAGR of around 7.1%. The market is expected to reap positive results from the Asia Pacific region where the demand for oral cancer treatment is expected to be high due to a large proportion of the young population residing in these countries and the increasing demand for tobacco and alcohol in these regions which are the major causes of oral cancer. Moreover, the segment by application is expected to contribute maximum towards oral cancer treatment market share.


COVID 19 Analysis:


The novel coronavirus or the Covid 19 pandemic has negatively impacted the oral cancer industry since the rising number of oral cancer cases have faced a standstill due to reduced demand for tobacco products which has created a negative impact on the oral cancer treatment industry and the oral cancer treatment companies have faced shortages in personnel, accumulated stocks, and forced shutdowns. Due to the lockdowns in various countries, the demand for oral cancer treatment has significantly reduced due to the restriction of people in moving freely and also people avoiding much of their visits to the health care places until there’s an emergency. Due to the Covid 19 effect, it has been observed that a large number of oral cancer treatment companies are forced to lay off employees but it is assumed that the market will soon pick up the pace and the demand would increase. It is expected that the post-lockdown period would be a great success for the oral cancer treatment market revenue. It is also analyzed that every segment would be contributing significantly towards the growth of oral cancer treatment market value.


MARKET DYNAMICS


Drivers:


The oral cancer market has been experiencing a diversified growth in all segments and across different regions due to the rising populations and the increasing per capita incomes of people which has shifted the demands of people to highly sophisticated and technologically advanced products and equipment which have acted as a motivating factor to the oral cancer market.


Secondly, the increased consumption of tobacco products and alcoholic liquor which have drastic effects and is seen as the major cause of oral cancer among the youth and around all the parts of the globe has been a major key driver which has boosted oral cancer treatment market share and created a positive trend.


Another major driver in the global oral cancer treatment market has been the ever-increasing health awareness programs and missions which have motivated people all over the world towards improvement in their health stats and to also be aware of the diseases that can be caused due to the consumption of various products. Also, the improvement in health care facilities all around the world has facilitated the oral cancer treatment market to have vast growth.


Restraints:


The overall growth in the oral cancer market has been expediently rising but certain factors hinder the growth process of the market which include large sums of money to be invested initially in setting up of oral cancer treatment companies and thus it restricts various new players to enter the markets.


Another key factor that acts as a barrier towards an increase in oral cancer treatment market share is the risk associated with the treatment of cancer and also the recurrence of cancer even after the treatment whichl remains one of the major drawbacks and makes the situation of the patients even worse because even after the painful treatment processes and surgeries, cancer can still return being more deadly.


Another key restraint that has been observed off late is the high cost of the oral cancer treatment which bars most of the patients who are not aptly equipped with all the financial resources and also affects the oral cancer treatment market share since it cannot cater to the diverse variety of patients of different sections of the society.


Technology Analysis:


The oral cancer treatment market trends have been dedicated towards the use of improved technology in the treatment process since the procedure for oral cancer treatment is based on highly scientific procedures and methods, it is usually carried on with the help of advanced tools and machines.


However, to be more specific, oral cancer treatment procedures involve radiation therapy, targeted therapy, chemotherapy, and other surgeries which are all based on the chemical processes and the use of UV radiations as part of technology for overcoming and curing oral cancer significantly.


The technological system to be used soon in the oral cancer treatment market involves using robotics and artificial intelligence systems to provide for the specific and timely location of cancer and then proceed with the treatment process and to remove cancer by minimizing every threat associated with the treatment and also ensuring that cancer does not return after the treatment.


Study Objectives:


To analyze the trends that are prevalent in the global oral cancer treatment market regions and players that will dominate the global trends and lead the oral cancer treatment market operations towards growth figures that have been predicted by the prominent leaders in the international oral cancer treatment market and key experts for the ongoing forecast period that ends in 2028.


To understand the scale of functioning of the global oral cancer treatment market segments that are prevalent through their ability to meet the vibrant needs of the target audience for market products and services.


To draw a competitive scale amongst the global oral cancer treatment market players and to understand the recent developments of the key oral cancer treatment market players in the recent past that promise great results to the market for the ongoing forecast period and automotive refinish coating market trends that end in 2028.  


Segment Overview:


The oral cancer market has been segmented as follows:


By Product Type



  • Squamous Cell Carcinoma

  • Verrucous Carcinoma

  • Minor Salivary Gland Carcinomas

  • Lymphomas


By Treatment



  • Surgery

  • Radiation Therapy

  • Targeted Therapy

  • Chemotherapy

  • Other Treatments


By Application



  • Hospitals And Clinics

  • Research Organization

  • Academic Institutes


By Region


North America


  • The U.S.

  • Canada

  • Mexico


Europe



  • Germany

  • France

  • UK

  • Italy


Asia-Pacific



  • Japan

  • China

  • Australia

  • India


LAMEA



  • Brazil

  • Saudi Arabia

  • South Africa


Regional Analysis:


The global oral cancer market has been divided into five regions where each region has been contributing significantly in terms of its capabilities and population demands. However, among the five regions, the Asia Pacific region has been accounting for the major oral cancer market share whereby the key drivers towards the growth of the oral cancer industry are developed here, and the population seems to be quite interested in the innovations in terms of new products in the market.


The major oral cancer market revenue is expected to come from countries like China, Japan, Korea, and India. The oral cancer statistics indicate that the population along with the disposable incomes of people of these countries has been increasing which has led to shifts in lifestyles and changing demands. The shift of the people towards health awareness and oral hygiene has contributed towards the growth of the market in this region.


The European region has also been experiencing major growth with contributions coming from developed nations such as France, Germany, Denmark, Belgium, etc. since most of the people in these countries have been consuming alcoholic liquor which has increased the number of cases in this region rapidly. The North American region is also experiencing vast growth in oral cancer market shares as the countries in this region have been reaping the benefits of technology thereby maximizing the level of operations and reducing operational cost.


Competitive Landscape:


The competitive landscape in terms of the oral cancer treatment market has been immense and nail-biting with new players easily entering the market and the existing players making huge investments in this segment.



  • Bristol-Myers Squibb Company (the U.S.)

  • Qilu Pharmaceutical Co., Ltd. (Asia Pacific)

  • Teva Pharmaceutical Industries Ltd. (Israel)

  • Eli Lilly and Company. (U.S.)

  • F Hoffmann-La Roche Ltd (Europe)

  • Merck & Co., Inc. (U.S.)

  • Novartis AG (Europe)

  • Pfizer Inc. (U.S.)


The key players in the market are more focused on developing future strategies and set themselves as joint ventures to increase the oral cancer treatment market share and size.


Recent Developments:



  • Recently, nanotechnology-based carrier systems have been introduced for oral cancer treatment whereby due to chemical and physical properties the nanoparticles show an increased response towards the drug delivery system and also reduce toxicity associated with the treatment process.

  • Recently, Takeda Pharmaceutical company announced that it is going to acquire Gammadelta therapeutics Limited, a company that has been focused on using unique properties of cells for immunotherapy. This would allow the principal company to use all the intellectual rights of the acquired company to its benefit.

  • Roche is launching a new profiling kit that helps cancer researchers to analyze tumors easily without having to send tissue samples to centralized laboratories. This would be a significant boost in the medical cancer research market.


Report Overview:


The Global report helps the investors to gain meaningful information about the oral cancer treatment market and make decisions wisely. The report discusses the steps taken by the oral cancer treatment market leaders to boost the market growth and inflate market valuation for their good. The report fully summarises the ongoing market scenario in the oral cancer treatment market which would help the intended audience to seek more information about the market. The objective of the report was to fully summarise the key players in the market and their role in boosting the oral cancer market value. The report also discusses the future growth prospects and the competitive landscape in the oral cancer treatment industry and lays down the expected growth rate of the market along with the hindrances it may face.


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.1% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatment, and End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Bristol-Myers Squibb Company (U.S.) Qilu Pharmaceutical Co., Ltd. (Asia Pacific), Teva Pharmaceutical Industries Ltd. (Isarael), Eli Lilly and Company. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Merck & Co., Inc. (U.S.), Novartis AG (Europe), Pfizer Inc. (U.S.), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of oral cancer
  • Rising per capita healthcare expenditures
  • Growing awareness about oral diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Oral cancer treatment market is expected to exhibit 7.1% CAGR from 2018 to 2023.

    The Americas can dominate the global oral cancer treatment market due to high cases of oral cancer.

    Asia Pacific can display a robust growth rate in the global oral cancer treatment market.

    The Middle East & Africa region is deemed to display a below average growth rate in the global oral cancer treatment market.

    Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Qilu Pharmaceutical Co., Ltd., Pfizer Inc., and Teva Pharmaceutical Industries Ltd. are major players of the global oral cancer treatment market.

    TABLE OF CONTENT

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Oral Cancer Treatment Market, by Type

    6.1 Introduction

    6.2 Squamous Cell Carcinoma

    Market Estimates & Forecast, 2020-2027

    6.3 Verrucous Carcinoma

    Market Estimates & Forecast, 2020-2027

    6.4 Minor Salivary Gland Carcinomas

    Market Estimates & Forecast, 2020-2027

    6.5 Lymphomas

    Market Estimates & Forecast, 2020-2027

    6.6 Others

    Chapter 7. Global Oral Cancer Treatment Market, by Treatment

    7.1 Introduction

    7.2 Surgery

    Market Estimates & Forecast, 2020-2027

    7.2.1 Tumor Resection

    7.2.2 Glossectomy

    7.2.3 Laryngectomy

    7.2.4 Mohs Micrographic Surgery

    7.2.5 Others

    7.3 Radiotherapy

    Market Estimates & Forecast, 2020-2027

    7.4 Chemotherapy

    Market Estimates & Forecast, 2020-2027

    7.4.1 Cisplatin

    7.4.2 Carboplatin

    7.4.3 5-fluorouracil (5-FU)

    7.4.4 Others

    7.5 Photodynamic Therapy (PDT)

    Market Estimates & Forecast, 2020-2027

    7.6 Others

    Chapter 8. Global Oral Cancer Treatment Market, by End Users

    8.1 Introduction

    8.2 Hospitals & Clinics

    Market Estimates & Forecast, 2020-2027

    8.3 Research Organization

    Market Estimates & Forecast, 2020-2027

    8.4 Academic Institutes

    Market Estimates & Forecast, 2020-2027

    8.5 Others

    Chapter 9. Global Oral Cancer Treatment Market, by Region

    9.1 Introduction

    9.2 America

    9.2.1 North America

    9.2.1.1 US

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 U.K

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic of Korea

    9.4.6 Rest of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest of the Middle East & Africa

    Chapter 10. Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    Chapter 11 Company Profiles

    11.1 Bristol-Myers Squibb Company

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.2.4 Key Developments

    11.1.5 SWOT Analysis

    11.2 Qilu Pharmaceutical Co., Ltd.

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Teva Pharmaceutical Industries Ltd.

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Eli Lilly and Company.

    11.4.1 Company Overview

    11.4.2 Product/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 F. Hoffmann-La Roche Ltd

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Merck & Co., Inc.

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 Novartis AG

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Pfizer Inc.

    11.8.1 Overview

    11.8.2 Product Overview

    11.8.3 Financials

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 Others

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Prediction of Oral Cancer Industry

    Chapter 13 Appendix

    LIST OF TABLES

    Table 1 Oral Cancer Treatment Industry Synopsis, 2020-2027

    Table 2 Global Oral Cancer Treatment Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Oral Cancer Treatment Market by Region, 2020-2027, (USD Million)

    Table 4 Global Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 5 Global Oral Cancer Treatment Market by Treatment, 2020-2027, (USD Million)

    Table 6 Global Oral Cancer Treatment Market by End Users, 2020-2027, (USD Million)

    Table 7 North America Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 8 North America Oral Cancer Treatment by Treatment, 2020-2027, (USD Million)

    Table 9 North America Oral Cancer Treatment by End Users, 2020-2027, (USD Million)

    Table 10 U.S. Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 11 U.S. Oral Cancer Treatment Market by Treatment, 2020-2027, (USD Million)

    Table 12 U.S. Oral Cancer Treatment Market by End Users, 2020-2027, (USD Million)

    Table 13 Canada Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 14 Canada Oral Cancer Treatment Market by Treatment, 2020-2027, (USD Million)

    Table 15 Canada Oral Cancer Treatment Market by End Users, 2020-2027, (USD Million)

    Table 16 South America Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 17 South America Oral Cancer Treatment Market by Treatment, 2020-2027, (USD Million)

    Table 18 South America Oral Cancer Treatment Market by End Users, 2020-2027, (USD Million)

    Table 19 Europe Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 20 Europe Oral Cancer Treatment Market by Treatment, 2020-2027, (USD Million)

    Table 21 Europe Oral Cancer Treatment Market by End Users, 2020-2027, (USD Million)

    Table 22 Western Europe Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 23 Western Europe Oral Cancer Treatment Market by Treatment, 2020-2027, (USD Million)

    Table 24 Western Europe Oral Cancer Treatment Market by End Users, 2020-2027, (USD Million)

    Table 25 Eastern Europe Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 26 Eastern Europe Oral Cancer Treatment Market by Treatment, 2020-2027, (USD Million)

    Table 27 Eastern Europe Oral Cancer Treatment Market by End Users, 2020-2027, (USD Million)

    Table 28 Asia Pacific Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 29 Asia Pacific Oral Cancer Treatment Market by Treatment, 2020-2027, (USD Million)

    Table 30 Asia Pacific Oral Cancer Treatment Market by End Users, 2020-2027, (USD Million)

    Table 31 Middle East & Africa Oral Cancer Treatment Market by Type, 2020-2027, (USD Million)

    Table 32 Middle East & Africa Oral Cancer Treatment Market by Treatment, 2020-2027, (USD Million)

    Table 33 Middle East & Africa Oral Cancer Treatment Market by End Users, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Oral Cancer Treatment Market

    Figure 3 Market Dynamics for Global Oral Cancer Treatment Market

    Figure 4 Global Oral Cancer Treatment Market Share, by Type 2020

    Figure 5 Global Oral Cancer Treatment Market Share, by Treatment 2020

    Figure 6 Global Oral Cancer Treatment Market Share, by End Users, 2020

    Figure 7 Global Oral Cancer Treatment Market Share, by Region, 2020

    Figure 8 North America Oral Cancer Treatment Market Share, by Country, 2020

    Figure 9 Europe Oral Cancer Treatment Market Share, by Country, 2020

    Figure 10 Asia Pacific Oral Cancer Treatment Market Share, by Country, 2020

    Figure 11 Middle East & Africa Oral Cancer Treatment Market Share, by Country, 2020

    Figure 12 Global Oral Cancer Treatment Market: Company Share Analysis, 2020 (%)

    Figure 13 Bristol-Myers Squibb Company: Key Financials

    Figure 14 Bristol-Myers Squibb Company: Segmental Revenue

    Figure 15 Bristol-Myers Squibb Company: Geographical Revenue

    Figure 16 Qilu Pharmaceutical Co., Ltd.: Key Financials

    Figure 17 Qilu Pharmaceutical Co., Ltd.: Segmental Revenue

    Figure 18 Qilu Pharmaceutical Co., Ltd.: Geographical Revenue

    Figure 19 Teva Pharmaceutical Industries Ltd.: Key Financials

    Figure 20 Teva Pharmaceutical Industries Ltd.: Segmental Revenue

    Figure 21 Teva Pharmaceutical Industries Ltd.: Geographical Revenue

    Figure 22 Eli Lilly and Company.: Key Financials

    Figure 23 Eli Lilly and Company.: Segmental Revenue

    Figure 24 Eli Lilly and Company.: Geographical Revenue

    Figure 25 F. Hoffmann-La Roche Ltd: Key Financials

    Figure 26 F. Hoffmann-La Roche Ltd: Segmental Revenue

    Figure 27 F. Hoffmann-La Roche Ltd: Geographical Revenue

    Figure 28 Merck & Co., Inc.: Key Financials

    Figure 29 Merck & Co., Inc.: Segmental Revenue

    Figure 30 Merck & Co., Inc.: Geographical Revenue

    Figure 31 Novartis AG: Key Financials

    Figure 32 Novartis AG: Segmental Revenue

    Figure 33 Novartis AG: Geographical Revenue

    Figure 34 Pfizer Inc.: Key Financials

    Figure 35 Pfizer Inc.: Segmental Revenue

    Figure 36 Pfizer Inc.: Geographical Revenue